Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

    Junker, A. E., Gluud, Lise Lotte, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, May 2016, In: Journal of Internal Medicine. 279, 5, p. 485–493 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment

    Storgaard, H., Bagger, J. I., Knop, Filip Krag, Vilsbøll, Tina & Rungby, Jørgen, Feb 2016, In: Basic & Clinical Pharmacology & Toxicology. 118, 2, p. 168-170 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

    Demant, M., Bagger, J. I., Suppli, M. P., Lund, A., Gyldenløve, M., Hansen, K. B., Hare, Kristine Juul, Christensen, Mikkel Bring, Sonne, D. P., Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Dec 2018, In: Metabolic Syndrome and Related Disorders. 16, 10, p. 530-536 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, J. M., 1 Aug 2002, In: Diabetologia. 45, 8, p. 1111-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Data on the use of dietary supplements in Danish patients with type 1 and type 2 diabetes

    Ewers, B., Trolle, E., Jacobsen, S. S., Vististen, D., Almdal, Thomas Peter, Vilsbøll, Tina & Bruun, J. M., 2019, In: Data in Brief. 22, p. 241-244 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial

    Nielsen, C. K., Øhrstrøm, C. C., Houji, I. J. K., Helsted, M. M., Krogh, L. S. L., Johansen, N. J., Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2023, In: Diabetes Care. 46, 12, p. 2208-2217 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

    Nielsen, C. K., Øhrstrøm, C. C., Kielgast, U. L., Hansen, D. L., Hartmann, Bolette, Holst, Jens Juul, Lund, Asger Bach, Vilsbøll, Tina & Knop, Filip Krag, 2022, In: Diabetes Care. 45, 6, p. 1476–1481

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Dapagliflozin plus saxagliptin add-on therapy compared with insulin in patients with type 2 diabetes poorly controlled by metformin with or without sulfonylurea therapy: A randomized clinical trial

    Vilsbøll, Tina, Ekholm, E., Johnsson, E., Dronamraju, N., Jabbour, S. & Lind, M., 2019, In: Diabetes Care. 42, 8, p. 1464-1472 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes

    Rhee, N. A., Vilsbøll, Tina & Knop, Filip Krag, 2012, In: Diabetes, Obesity and Metabolism. 14, 4, p. 291-298

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

    Grøndahl, M. F., Keating, D. J., Vilsbøll, Tina & Knop, Filip Krag, 2017, In: Current Diabetes Reports. 17, 12, 10 p., 128.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Counterregulatory responses to hypoglycaemia in totally pancreatectomised patients

    Baekdal, M., Lund, A., Baldassare, M. P. A., Rose, K., Egholk, J., Christensen, M. B., Hansen, C. P., Storkholm, J. H., Faber, Jens, Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2020, In: Diabetologia. 63, SUPPL 1, p. S95-S95

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  12. E-pub ahead of print

    Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine

    Simonson, D. C., Testa, M. A., Ekholm, E., Su, M., Vilsbøll, Tina, Jabbour, S. A. & Lind, M., 2024, (E-pub ahead of print) In: The Journal of Clinical Endocrinology & Metabolism. p. 1-12

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings

    Holst, Jens Juul & Vilsbøll, Tina, 2013, In: Diabetes, Obesity and Metabolism. 15, 1, p. 3-14 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling

    Gether, I. M., Bahne, E., Nerild, H. H., Rehfeld, Jens Frederik, Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina, Sonne, David Peick & Knop, Filip Krag, 2024, In: European Journal of Endocrinology. 190, 4, p. 314-326 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes

    Harris, S., Abrahamson, M. J., Ceriello, A., Charpentier, G., Evans, M., Lehmann, R., Liebl, A., Linjawi, S., Holt, R. I. G., Hosszúfalusi, N., Rutten, G. & Vilsbøll, Tina, 2020, In: Drugs. 80, 2, p. 147-165 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  16. Published

    Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

    Fotheringham, A. K., Bagger, J. I., Borg, D. J., McCarthy, D. A., Holst, Jens Juul, Vilsbøll, Tina, Knop, Filip Krag & Forbes, J. M., 2020, In: Nutrients. 12, 10, 12 p., 2928.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

    Albrechtsen, N. J. W., Kuhre, R. E., Hornburg, D., Jensen, C. Z., Hornum, M., Dirksen, C., Svane, M., Gasbjerg, L. S., Jorgensen, N. B., Gabe, M. N., Balk-Moller, E., Albrechtsen, R., Winther-Sorensen, M., Galsgaard, K. D., Meissner, F., Jorsal, T., Lund, A., Vilsboll, T., Eliasen, R., Bojsen-Moller, K. N. & 9 others, Idorn, T., Deacon, Carolyn F., Knop, Filip Krag, Rosenkilde, Mette, Hartmann, Bolette, Feldt-Rasmussen, Bo, Mann, Matthias, Madsbad, Sten & Holst, Jens Juul, Nov 2017, In: Cell Reports. 21, 6, p. 1452-1460

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes

    Jørgensen, P. G., Jensen, M. T., Biering-Sørensen, Tor, Møgelvang, R., Galatius, S., Hansen, T. F., Rossing, Peter, Vilsbøll, Tina & Jensen, J. S., 22 Sep 2016, In: Cardiovascular Diabetology. 15, 1, 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Cholecystokinin-Induced Gallbladder Emptying and Single-Dose Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

    Rohde, U., Sonne, D. P., Christensen, M., Hansen, M., Brønden, A., Toräng, S., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 1 May 2016, In: The Journal of clinical endocrinology and metabolism. 101, 5, p. 2076-2083

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Characterization of oral and intravenous glucose handling in truncally vagotomised subjects with pyloroplasty

    Plamboeck, A., Veedfald, Simon, Deacon, Carolyn F., Hartmann, Bolette, Wettergren, A., Svendsen, Lars Bo, Meisner, S., Hovendal, C., Knop, Filip Krag, Vilsbøll, Tina & Holst, Jens Juul, 23 May 2013, In: European Journal of Endocrinology. 169, p. 187-201 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Changes in urinary excretion of oxidative nucleic acid modifications in the week following Copenhagen Marathon 2018, Denmark

    Larsen, E. L., Kjær, L. K., Michaelsen, C., Andersen, E., Lyngbæk, M., Petersen-bønding, C., Henriksen, T., Vilsbøll, Tina, Knop, Filip Krag, Ploug, Thorkil, Poulsen, Henrik Enghusen & Karstoft, K., 2018, In: Free Radical Biology and Medicine. 128, S1, p. S54

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  22. Published

    Changes in the use of glucose-lowering drugs: A Danish nationwide study

    Pottegård, A., Andersen, J. H., Søndergaard, J., Thomsen, R. W. & Vilsbøll, Tina, 2023, In: Diabetes, Obesity and Metabolism. 25, 4, p. 1002-1010

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: Two randomised, placebo-controlled trials

    Brønden, A., Larsen, E. L., Karstoft, K., Henriksen, T., Vilsbøll, Tina, Poulsen, Henrik Enghusen & Knop, Filip Krag, Feb 2020, In: Journal of Diabetes and its Complications. 34, 2, 8 p., 107446.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Changes in oxidative RNA and DNA modifications following one-week treatment with sevelamer: two randomized, placebo-controlled trials

    Larsen, E. L., Brønden, A., Karstoft, K., Henriksen, T., Vilsbøll, Tina, Poulsen, Henrik Enghusen & Knop, Filip Krag, 2018, In: Free Radical Biology and Medicine. 128, p. S118 280.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  25. Published

    Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes

    Wretlind, A., Curovic, V. R., Suvitaival, T., Theilade, Karen Simone, Tofte, N., Winther, S. A., Vilsbøll, Tina, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2023, In: Diabetes. 72, 10, p. 1493-1501 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

    Wretlind, A., Curovic, V. R., de Zawadzki, A., Suvitaival, T., Xu, J., Zobel, E. H., von Scholten, B. J., Ripa, Rasmus Sejersten, Kjær, Andreas, Hansen, T. W., Vilsbøll, Tina, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2023, In: Lipids in Health and Disease. 22, 1, 12 p., 160.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Cephalic phase secretion of insulin and other enteropancreatic hormones in humans

    Veedfald, Simon, Plamboeck, A., Deacon, Carolyn F., Hartmann, Bolette, Knop, Filip Krag, Vilsbøll, Tina & Holst, Jens Juul, 1 Jan 2016, In: American Journal of Physiology: Gastrointestinal and Liver Physiology. 310, 1, p. G43-51

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Cardiovascular safety and benefits of GLP-1 receptor agonists

    Dalsgaard, N. B., Brønden, A., Vilsbøll, Tina & Knop, Filip Krag, 2017, In: Expert Opinion on Drug Safety. 16, 3, p. 351-363 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  29. Published

    Cardiovascular biomarkers in clinical studies of type 2 diabetes

    Baldassarre, M. P. A., Andersen, A., Consoli, A., Knop, Filip Krag & Vilsbøll, Tina, 2018, In: Diabetes, Obesity and Metabolism. 20, 6, p. 1350-1360

    Research output: Contribution to journalReviewResearchpeer-review

  30. Published

    CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

    Schnell, O., Barnard-Kelly, K., Battelino, T., Ceriello, A., Larsson, H. E., Fernández-Fernández, B., Forst, T., Frias, J. P., Gavin, J. R., Giorgino, F., Groop, P. H., Heerspink, H. J. L., Herzig, S., Hummel, M., Huntley, G., Ibrahim, M., Itzhak, B., Jacob, S., Ji, L., Kosiborod, M. & 23 others, Lalic, N., Macieira, S., Malik, R. A., Mankovsky, B., Marx, N., Mathieu, C., Müller, T. D., Ray, K., Rodbard, H. W., Rossing, Peter, Rydén, L., Schumm-Draeger, P. M., Schwarz, P., Škrha, J., Snoek, F., Tacke, F., Taylor, B., Jeppesen, B. T., Tesfaye, S., Topsever, P., Vilsbøll, Tina, Yu, X. & Standl, E., 2024, In: Cardiovascular Diabetology. 23, 1, 17 p., 104.

    Research output: Contribution to journalComment/debateResearchpeer-review

  31. Published

    CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., Davies, M., Edelman, S., Forst, T., Giorgino, F., Green, J., Groop, P. H., Hadjadj, S., J.L.Heerspink, H., Hompesch, M., Izthak, B., Ji, L., Kanumilli, N., Mankovsky, B., Mathieu, C. & 16 others, Miszon, M., Mustafa, R., Nauck, M., Pecoits-Filho, R., Pettus, J., Ranta, K., Rodbard, H. W., Rossing, Peter, Ryden, L., Schumm-Draeger, P. M., Solomon, S. D., Škrha, J., Topsever, P., Vilsbøll, Tina, Wilding, J. & Standl, E., 2023, In: Cardiovascular Diabetology. 22, 1, 59.

    Research output: Contribution to journalComment/debateResearchpeer-review

  32. Published

    Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus

    Jørgensen, P. G., Jensen, M. T., Biering-Sørensen, Tor, Mogelvang, R., Fritz-Hansen, T., Vilsbøll, Tina, Rossing, Peter & Jensen, J. S., 2018, In: Journal of the American Heart Association. 7, 19, p. 1-12 e008856.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, J. J., 15 Jul 2003, In: Regulatory Peptides. 114, 2-3, p. 115-121 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose

    Maagensen, H., Junker, A. E., Jorgensen, N. R., Gluud, Lise Lotte, Knop, Filip Krag & Vilsbøll, Tina, 2018, In: Journal of Clinical Endocrinology & Metabolism. 103, 5, p. 2042-2049 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Biomarkører for kardiovaskulær sygdom ved type 2-diabetes

    Krogh, S. K., Andersen, A., Knop, Filip Krag & Vilsbøll, Tina, 2019, In: Ugeskrift for Laeger. 181, 6 p., V10180711.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

    Hansen, M., Sonne, David Peick, Mikkelsen, K. H., Gluud, Lise Lotte, Vilsbøll, Tina & Knop, Filip Krag, May 2017, In: Journal of Diabetes and its Complications. 31, 5, p. 918-927 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    Betydningen af inkretinhormonerne glucose-dependent insulinotropic peptide og glucagon-like peptide-1 for patogenesen ved type 2-diabetes mellitus

    Vilsbøll, Tina & Knop, Filip Krag, 28 May 2007, In: Ugeskrift for Laeger. 169, 22, p. 2101-5 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

    Rodbard, H. W., Buse, J. B., Woo, V. C., Vilsbøll, Tina, Langbakke, I. H., Kvist, K. & Gough, S. C. L., Jan 2016, In: Diabetes, Obesity and Metabolism. 18, 1, p. 40-48 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

    Storgaard, H., Gluud, Lise Lotte, Bennett, C., Grøndahl, M. F., Christensen, Mikkel Bring, Knop, Filip Krag & Vilsbøll, Tina, 2016, In: PLOS ONE. 11, 11, 23 p., e0166125.

    Research output: Contribution to journalReviewResearchpeer-review

  40. Published

    Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

    Courrèges, J., Vilsbøll, Tina, Zdravkovic, M., Le Thi Thanh, X., Krarup, T., Schmitz, O., Verhoeven, R., Bugáñová, I. & Madsbad, Sten, 1 Sep 2008, In: Diabetic Medicine. 25, 9, p. 1129-31 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study

    Andersen, A., Bagger, J. I., Sørensen, S. K., Baldassarre, M. P. A., Pedersen-Bjergaard, Ulrik, Forman, Julie Lyng, Gislason, Gunnar Hilmar, Lindhardt, T. B., Knop, Filip Krag & Vilsbøll, Tina, 2021, In: Cardiovascular Diabetology. 20, 1, 10 p., 241.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Associations of hypoglycaemia and glycaemic variability with cardiac arrhythmias using a long-term monitoring approach in insulin-treated patients with type 2 diabetes

    Andersen, A., Bagger, J. I., Sorensen, S. K., Baldassarre, M. P. A., Pedersen-Bjergaard, Ulrik, Forman, Julie Lyng, Gislason, Gunnar Hilmar, Lindhardt, T. B., Knop, Filip Krag & Vilsbøll, Tina, 2021, In: Diabetologia. 64, SUPPL 1, p. 135-135 257.

    Research output: Contribution to journalConference abstract in journalResearch

  43. Published

    Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes

    Kim, A., Knudsen, J. G., Madara, J. C., Benrick, A., Hill, T. G., Kadir, L. A., Kellard, J. A., Mellander, L., Miranda, C., Lin, H., James, T., Suba, K., Spigelman, A. F., Wu, Y., Macdonald, P. E., Asterholm, I. W., Magnussen, T., Christensen, M., Vilsbøll, T., Salem, V. & 4 others, Knop, Filip Krag, Rorsman, P., Lowell, B. B. & Briant, L. J. B., 2021, In: eLife. 10, 29 p., e72919.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight

    Theilade, Karen Simone, Christensen, Mikkel Bring, Vilsbøll, Tina & Knop, Filip Krag, 2021, In: Diabetes, Obesity and Metabolism. 23, S1, p. 17-35 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  45. Published

    An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetes

    Jørgensen, P. G., Schou, Morten, Biering-Sørensen, Tor, Mogelvang, R., Fritz-Hansen, T., Vilsbøll, Tina, Rossing, Peter & bqn654, bqn654, 2019, In: International Journal of Cardiology. 289, p. 119-124 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    An Extended Minimal Model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect

    Subramanian, V., Bagger, J. I., Harihar, V., Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, 2024, In: American Journal of Physiology - Endocrinology and Metabolism. 326, 2, p. E182-E205

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

    Mathiesen, D. S., Lund, A., Vilsbøll, Tina, Knop, Filip Krag & Bagger, J. I., 2021, In: Frontiers in Endocrinology. 11, 617400.

    Research output: Contribution to journalReviewResearchpeer-review

  48. Published

    Alcohol consumption among patients with diabetes: a survey-based cross-sectional study of Danish adults with diabetes

    Jakobsen, M. L., Larsen, J. R., Glumer, C., Juel, K., Ekholm, O., Vilsbøll, Tina, Becker, U. & Fink-Jensen, Anders, Jul 2016, In: Scandinavian Journal of Public Health. 44, 5, p. 517-524

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Akutte Medicinske TIlstande

    Godtfredsen, Nina, Kruuse, Christina Rostrup, Petersen, Andreas Munk, Tfelt-Hansen, Jacob & Vilsbøll, Tina, Dec 2014, 11 ed. FADL's Forlag.

    Research output: Book/ReportBookEducation

  50. Published

    Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes-focus on pancreatitis and pancreas cancer

    Chalmer, T., Almdal, Thomas Peter, Vilsbøll, Tina & Knop, Filip Krag, 2015, In: Expert Opinion on Drug Safety. 14, 1, p. 171-180

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1...4 5 6 7 8 9 Next

ID: 33056950